Transfer
Patent
-
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (GPRC5D)
Inventors: SATHER, Blythe D.; SMITH, Eric L.; DE IMUS, Cyr; HARRINGTON, Kimberly; JONES, Jon; CHEN, Aye; TAREEN, Semih; HESS, Erik; PONKO, Stefan; OLSHEFSKY, Audrey; FERNANDEZ DE LARREA, Carlos; BRENTJENS, Renier
Owner(s): JUNO THERAPEUTICS, INC., MEMORIAL SLOAN KETTERING CANCER CENTER
Patent reference (priority number, PCT or WO publication number): PCT/US20 19/059285
Patent publication code: WO 2020/092854 A2
Patent publication date: 07/05/2020
Filing date: 31 October 2019
Clinical guides
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Auhors: Fernández de Larrea C, Kyle R, Rosiñol L, Paiva B, Engelhardt M, Usmani S, Caers J, Gonsalves W, Schjesvold F, Merlini G, Lentzch S, Ocio E, Garderet L, Moreau P, Sonneveld P, Badros A, Gahrton G, Goldschmidt H, Tuchman S, Einsele H, Durie B, Wirk B, Musto P, Hayden P, Kaiser M, Miguel JS, Bladé J, Rajkumar SV, Mateos MV.
Reference: Blood Cancer J 2021;11(12):192.
-
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations
Authors: Rosiñol L, Beksac M, Zamagni E, Van de Donk NWCJ, Anderson KC, Badros A, Caers J, Cavo M, Dimopoulos MA, Dispenzieri A, Einsele H, Engelhardt M, Fernández de Larrea C, Gahrton G, Gay F, Hájek R, Hungria V, Jurczyszyn A, Kröger N, Kyle RA, Leal da Costa F, Leleu X, Lentzsch S, Mateos MV, Merlini G, Mohty M, Moreau P, Rasche L, Reece D, Sezer O, Sonneveld P, Usmani SZ, Vanderkerken K, Vesole DH, Waage A, Zweegman S, Richardson PG, Bladé J.
Reference: Br J Haematol 2021;194(3):496-507.
-
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
Authors: Musto P, Engelhardt M, Caers J, Bolli N, Kaiser M, Van de Donk N, Terpos E, Broijl A, Fernandez de Larrea C, Gay F, Goldschmidt H, Hajek R, Vangsted AJ, Zamagni E, Zweegman S, Cavo M, Dimopoulos M, Einsele H, Ludwig H, Barosi G, Boccadoro M, Mateos MV, Sonneveld P, Miguel JS.
Reference: Haematologica 2021;106(11):2799-2812.
-
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma.
Authors: Bruno B, Wäsch R, Engelhardt M, Gay F, Giaccone L, D'Agostino M, Rodríguez-Lobato LG, Danhof S, Gagelmann N, Kröger N, Popat R, Van de Donk NWCJ, Terpos E, Dimopoulos MA, Sonneveld P, Einsele H, Boccadoro M.
Reference: Haematologica 2021;106(8):2054-2065.
-
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European expert panel
Authors: Caers, J.; Paiva, B.; Zamagni, E.; Leleu, X.; Bladé,J.; Kristinsson, S. Y.; Touzeau, C.; Abildgaard, N.;Terpos, E.; Heusschen, R.; Ocio, E.; Delforge, M.; Sezer, O.; Beksac, M.; Ludwig, H.; Merlini, G.; Moreau, P.; Zweegman, S.; Engelhardt, M.; Rosiñol, L.
Reference: J Hematol Oncol 2018;11(1):10.
-
The changing landscape of smoldering multiple myeloma: a European perspective
Authors: Caers J, Fernández de Larrea C, Leleu X, Heusschen R, Zojer N, Decaux O, Kastritis E, Minnema M, Jurczyszyn A, Beguin Y, Wäsch R, Palumbo A, Dimopoulos M, Mateos MV, Ludwig H, Engelhardt M
Reference: Oncologist 2016; 21:333-342
-
How I treat relapsed myeloma
Authors: Bladé J, Rosiñol L, Fernández de Larrea C.
Reference: Blood 2015 125(10):1532-1540
-
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
Authors: Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, Hajek R, San Miguel JF, Sezer O, Sonneveld P, Kumar SK, Mahindra A, Comenzo R, Palumbo A, Mazumber A, Anderson KC, Richardson PG, Badros AZ, Caers J, Cavo M, LeLeu X, Dimopoulos MA, Chim CS, Schots R, Noeul A, Fantl D, Mellqvist UH, Landgren O, Chanan-Khan A, Moreau P, Fonseca R, Merlini G, Lahuerta JJ, Bladé J, Orlowski RZ, Shah JJ
Reference: Leukemia 2013; 27:780-791